Samantha Lynn Inc. Issues Voluntary Nationwide Recall of Reumofan Plus Tablets Due to Undeclared Drug Ingredients

Food & Drug Recalls

Samantha Lynn Inc. is voluntarily recalling 500 lots of Reumofan Plus Tablets to the consumer level due to findings of undeclared drug ingredients. The Food and Drug Administration (FDA) sample analysis has found the product to contain methocarbamol and diclofenac.